ITGAM and myelodysplastic syndrome: As reported by Repo et al. [29], this might be corrected by the use of higher amounts of the CD11b antibody (clone D12, i.e., the same as the one tested in the current study) for staining EDTA-anticoagulated samples—e.g., MDS patient samples.